These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 8088604

  • 21. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH, Fuller AF, Pastel-Ley C, Flotte TJ, Bell DA.
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [Abstract] [Full Text] [Related]

  • 22. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
    Hsu MM, Chiou CR, Ko JY, Sheen TS, Hong RL, Ting LL.
    Cancer Detect Prev; 2000 Apr; 24(2):119-26. PubMed ID: 10917131
    [Abstract] [Full Text] [Related]

  • 23. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T, Margallo E, Nesi G, Giubilei G, Rizzo M, Bartoletti R.
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [Abstract] [Full Text] [Related]

  • 24. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G, Lindholm K, Falkmer U, Abrahamsson PA.
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [Abstract] [Full Text] [Related]

  • 25. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
    Kapp KS, Poschauko J, Tauss J, Berghold A, Oechs A, Lahousen M, Petru E, Winter R, Kapp DS.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1399-404. PubMed ID: 16029799
    [Abstract] [Full Text] [Related]

  • 26. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H, Fortin A, Bairati I, Morency R, Monteil RA, Têtu B.
    Int J Oral Maxillofac Surg; 2000 Feb 01; 29(1):36-41. PubMed ID: 10691142
    [Abstract] [Full Text] [Related]

  • 27. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE, Veys JA, Eskridge MR, Woodruff RD, Hall MC.
    Urol Oncol; 2005 Feb 01; 23(5):328-32. PubMed ID: 16144666
    [Abstract] [Full Text] [Related]

  • 28. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM, Venkatraman E, Chi DS, Barakat RR.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):111-7. PubMed ID: 15850910
    [Abstract] [Full Text] [Related]

  • 29. Comparison between conventional surgery and radiotherapy for FIGO stage I-II cervical carcinoma: a retrospective Japanese study.
    Yamashita H, Nakagawa K, Tago M, Shiraishi K, Nakamura N, Ohtomo K, Oda K, Nakagawa S, Yasugi T, Taketani Y.
    Gynecol Oncol; 2005 Jun 01; 97(3):834-9. PubMed ID: 15894366
    [Abstract] [Full Text] [Related]

  • 30. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A, Masetti R, Breccia C, Coppola R, Magistrelli P, Nuzzo G, Maggiano N, Picciocchi A.
    Hepatogastroenterology; 1999 Jun 01; 46(26):1187-91. PubMed ID: 10370689
    [Abstract] [Full Text] [Related]

  • 31. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ, Nakhleh RE, Brown RD, Kubus JJ, Ma CK, Mackowiak P.
    Cancer; 1997 Jun 01; 79(11):2073-86. PubMed ID: 9179053
    [Abstract] [Full Text] [Related]

  • 32. DNA flow cytometry: a predictor of a high-risk group in cervical cancer.
    Anton M, Nenutil R, Rejthar A, Kopecny J, Ptackova B, Zaloudik J.
    Cancer Detect Prev; 1997 Jun 01; 21(3):242-6. PubMed ID: 9167041
    [Abstract] [Full Text] [Related]

  • 33. Prognostic significance of DNA ploidy and proliferative indices in patients with nasopharyngeal carcinoma.
    Ma J, Nicholas, Terry HA, Lin SX, Patel N, Mai HG, Hong MH, Lu TX, Cui NJ, Min HQ.
    Ai Zheng; 2002 Jun 01; 21(6):644-50. PubMed ID: 12452067
    [Abstract] [Full Text] [Related]

  • 34. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E, Kim RY, Meleth S, De Los Santos J, Spencer S.
    Brachytherapy; 2006 Jun 01; 5(1):49-55. PubMed ID: 16563997
    [Abstract] [Full Text] [Related]

  • 35. A ratio of apoptosis to mitosis, proliferation pattern and prediction of radiotherapy response in cervical carcinoma.
    Gasinska A, Urbanski K, Gruchala A, Biesaga B, Kojs Z.
    Neoplasma; 2002 Jun 01; 49(6):379-86. PubMed ID: 12584585
    [Abstract] [Full Text] [Related]

  • 36. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R, Wimberger P, Hillemanns P, Kapsner T, Caspari C, Hepp H.
    Gynecol Oncol; 2002 Jan 01; 84(1):21-31. PubMed ID: 11748971
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.